Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.
Akache B, Renner TM, Tran A, Deschatelets L, Dudani R, Harrison BA, Duque D, Haukenfrers J, Rossotti MA, Gaudreault F, Hemraz UD, Lam E, Régnier S, Chen W, Gervais C, Stuible M, Krishnan L, Durocher Y, McCluskie MJ.
Akache B, et al. Among authors: krishnan l.
Sci Rep. 2021 Nov 8;11(1):21849. doi: 10.1038/s41598-021-01363-7.
Sci Rep. 2021.
PMID: 34750472
Free PMC article.